---
layout: page-fullwidth
title: "Speakers & Presentations"
header: no
permalink: /speakers/
---

<div id="speaker1" style="display: flex; flex-direction: column;">

<h3>Super-Efficient Estimation of Average Treatment Effect based on Randomized Controlled Trial Augmented with External Controls or Observational Study Learning</h3>

<h4>Mark Van der Laan, University of California at Berkeley</h4>

<p>
<img class="imgfloat" src="../docs/mark_profile.jpeg"/>

Mark, who pioneered the widely acclaimed targeted maximum likelihood estimator (TMLE) approach for causal inference, will elucidate the validity of the framework in the context of augmenting control arms to generate valid and reliable evidence. 

</p>

</div>

----

<div id="speaker2" style="display: flex; flex-direction: column;">

<h3>Advancing Clinical Development through Real-World Data, AI and Machine Learning</h3>

<h4>Issa Dahabreh, Harvard University</h4>

<p>
<img class="imgfloat" src="../docs/Issa.jpg"/>

</p>

</div>

----

<div id="speaker3" style="display: flex; flex-direction: column;">

<h3>Sensitivity Analysis Strategies for Unmeasured Confounding when Integrating External Controls in Randomized Controlled Trials</h3>

<h4>Mingyang Shan, Eli Lilly</h4>

<p>
<img class="imgfloat" src="../docs/mingyang.jpeg"/>

From the perspective of pharmaceutical industry, Mingyang will share pertinent experiences with reference to alternative sensitivity analysis strategies in dealing with the issue of unmeasured confounding when incorporating external controls in RCTs. 
</p>

</div>

----

<div id="speaker4" style="display: flex; flex-direction: column;">

<h3>Regulatory and Statistical Considerations for Non-randomized Comparative Trials in Drug Development</h3>

<h4>Pallavi Mishra-Kalyani, US Food and Drug Administration (FDA)</h4>

<p>
<img class="imgfloat" src="../docs/Pallavi.jpeg"/>

Pallavi will highlight current regulatory thinking in the area and provide salient aspects of relevant guidelines aimed at fostering innovation in drug development. 
</p>

</div>

----

<div id="speaker5" style="display: flex; flex-direction: column;">

<h3>New Proposals in Clinical Study Design based on Applications of Differential Hermite and Propensity Scores Indices</h3>

<h4>Javier Cabrera, Rutgers University</h4>

<p>
<img class="imgfloat" src="../docs/cabrera.png"/>

</p>

</div>

----

<div id="speaker6" style="display: flex; flex-direction: column;">

<h3>Discussion</h3>

<h4>Demissie Alemayehu, Pfizer</h4>

<p>
<img class="imgfloat" src="../docs/Demissie.jpg"/>

Demissie will provide a synthesis of the ideas presented by the speakers and engage the participants and the audience to generate further insights.
</p>

</div>